30-Oct-2024
Application for quotation of securities - COH
30-Oct-2024
Application for quotation of securities - COH
25-Oct-2024
2024 AGM Results
15-Oct-2024
Notification of cessation of securities - COH
11-Oct-2024
Update - Notification of buy-back - COH
10-Oct-2024
Notification of cessation of securities - COH
10-Oct-2024
Notification regarding unquoted securities - COH
10-Oct-2024
Notification regarding unquoted securities - COH
10-Oct-2024
Update - Notification of buy-back - COH
9-Oct-2024
Update - Notification of buy-back - COH
7-Oct-2024
Update - Notification of buy-back - COH
4-Oct-2024
Update - Notification of buy-back - COH
3-Oct-2024
Update - Notification of buy-back - COH
30-Sep-2024
Update - Notification of buy-back - COH
26-Sep-2024
Appendix 3Y - Diggory Howitt
26-Sep-2024
Notification regarding unquoted securities - COH
26-Sep-2024
Update - Notification of buy-back - COH
24-Sep-2024
Update - Notification of buy-back - COH
23-Sep-2024
Update - Dividend/Distribution - COH
20-Sep-2024
Update - Notification of buy-back - COH
19-Sep-2024
Cochlear announces Chief Financial Officer appointment
19-Sep-2024
Update - Notification of buy-back - COH
18-Sep-2024
COH Notice of Annual General Meeting & Proxy/Voting Form
18-Sep-2024
Update - Notification of buy-back - COH
17-Sep-2024
Appendix 3Y - Diggory Howitt
17-Sep-2024
Notification regarding unquoted securities - COH
17-Sep-2024
Update - Notification of buy-back - COH
3-Sep-2024
Appendix 3X - Caroline Clarke
30-Aug-2024
Notification regarding unquoted securities - COH
30-Aug-2024
Appendix 3Y - Karen Penrose
28-Aug-2024
Appendix 3Y - Michael del Prado
27-Aug-2024
Becoming a substantial holder
27-Aug-2024
Amended notice of ceasing to be a substantial holder
26-Aug-2024
Notice of ceasing to be a substantial holder
23-Aug-2024
Becoming a substantial holder
23-Aug-2024
Appendix 3Y - Christine McLoughlin
23-Aug-2024
Appendix 3Y - Karen Penrose
22-Aug-2024
Appendix 3Y - Diggory Howitt
21-Aug-2024
Notification of cessation of securities - COH
20-Aug-2024
Notification regarding unquoted securities - COH
15-Aug-2024
Notification of buy-back - COH
15-Aug-2024
Appendix 4G
15-Aug-2024
Application for quotation of securities - COH
15-Aug-2024
Date of AGM and closing date for director nominations
15-Aug-2024
2024 Tax Contribution Report
15-Aug-2024
FY24 Result - Presentation
15-Aug-2024
FY24 Result - ASX & Media Release
15-Aug-2024
Dividend/Distribution - COH
15-Aug-2024
Appendix 4E
15-Aug-2024
Annual Report (incl Sustainability reporting)
30-Jul-2024
Appointment of Caroline Clarke to the Cochlear Board
26-Jul-2024
Cochlear announces changes to the executive team
25-Jul-2024
Application for quotation of securities - COH
10-Jul-2024
COH Notice of FY24 result analyst and media briefing
5-Jul-2024
Notification of cessation of securities - COH
5-Jul-2024
Notification regarding unquoted securities - COH
5-Jul-2024
Notification regarding unquoted securities - COH
23-May-2024
Change of registry address
21-May-2024
Cochlear acquires Demant cochlear implant business
20-May-2024
Change in substantial holding
30-Apr-2024
Application for quotation of securities - COH
22-Apr-2024
Appointments and retirement of Company Secretary
5-Apr-2024
Notification of cessation of securities - COH
4-Apr-2024
AXX: ACCC will not oppose revised Cochlear, Oticon transacti
2-Apr-2024
Appendix 3Z - Yasmin Allen
2-Apr-2024
Update - Dividend/Distribution - COH
25-Mar-2024
Resignation of Director - Yasmin Allen
15-Mar-2024
Appendix 3Y - Diggory Howitt
15-Mar-2024
Notification regarding unquoted securities - COH
28-Feb-2024
Notification regarding unquoted securities - COH
22-Feb-2024
Notification regarding unquoted securities - COH
19-Feb-2024
HY24 Result - Presentation Slides
19-Feb-2024
Update - Notification of buy-back - COH
19-Feb-2024
Appendix 4D and Half Year Financial Report
19-Feb-2024
Dividend/Distribution - COH
19-Feb-2024
HY24 Result - ASX & Media Release
8-Feb-2024
Cochlear Upgrades FY24 Earnings Guidance
8-Feb-2024
Cochlear Upgrades FY24 Earnings Guidance
12-Jan-2024
Notification of cessation of securities - COH
10-Jan-2024
Notification regarding unquoted securities - COH
8-Jan-2024
Notice of HY24 result analyst and media briefing
19-Dec-2023
Notification of cessation of securities - COH
7-Dec-2023
Notification regarding unquoted securities - COH
7-Dec-2023
Update - Notification of buy-back - COH
6-Dec-2023
Update - Notification of buy-back - COH
30-Nov-2023
Update - Notification of buy-back - COH
24-Nov-2023
Notification of cessation of securities - COH
23-Nov-2023
Update - Notification of buy-back - COH
16-Nov-2023
Appendix 3Y - Michael del Prado
10-Nov-2023
Update - Notification of buy-back - COH
9-Nov-2023
Update - Notification of buy-back - COH
8-Nov-2023
Ceasing to be a substantial holder
7-Nov-2023
Notification regarding unquoted securities - COH
3-Nov-2023
Notification of cessation of securities - COH
1-Nov-2023
Notification regarding unquoted securities - COH
1-Nov-2023
Update - Notification of buy-back - COH
31-Oct-2023
Update - Notification of buy-back - COH
30-Oct-2023
Application for quotation of securities - COH
27-Oct-2023
Cochlear Capital Markets Day Presentation
25-Oct-2023
Application for quotation of securities - COH
25-Oct-2023
Notification regarding unquoted securities - COH
23-Oct-2023
Appendix 3Y - Karen Penrose
23-Oct-2023
Appendix 3Y - Diggory Howitt
23-Oct-2023
Notification regarding unquoted securities - COH
19-Oct-2023
Notification regarding unquoted securities - COH
19-Oct-2023
Appendix 3Z - Andrew Denver
17-Oct-2023
2023 AGM Results
16-Oct-2023
Notification of cessation of securities - COH
12-Oct-2023
Notification of cessation of securities - COH
11-Oct-2023
Late Lodgement of Appendix 3H
11-Oct-2023
Notification of cessation of securities - COH
3-Oct-2023
Becoming a substantial holder
2-Oct-2023
Update - Notification of buy-back - COH
29-Sep-2023
Update - Notification of buy-back - COH
28-Sep-2023
Update - Notification of buy-back - COH
27-Sep-2023
Correction to Notice of Annual General Meeting
27-Sep-2023
Update - Notification of buy-back - COH
26-Sep-2023
Update - Dividend/Distribution - COH
26-Sep-2023
Update - Notification of buy-back - COH
25-Sep-2023
Update - Notification of buy-back - COH
22-Sep-2023
Notification of cessation of securities - COH
22-Sep-2023
Update - Notification of buy-back - COH
21-Sep-2023
Update - Notification of buy-back - COH
20-Sep-2023
Update - Notification of buy-back - COH
19-Sep-2023
Update - Notification of buy-back - COH
18-Sep-2023
Appendix 3Y - Diggory Howitt
18-Sep-2023
Notification regarding unquoted securities - COH
15-Sep-2023
COH Notice of Annual General Meeting and Voting Form
8-Sep-2023
Notification of cessation of securities - COH
7-Sep-2023
Update - Notification of buy-back - COH
6-Sep-2023
Notification regarding unquoted securities - COH
6-Sep-2023
Appendix 3Y - Karen Penrose
6-Sep-2023
Update - Notification of buy-back - COH
5-Sep-2023
Appendix 3Y - Christine Frances McLoughlin
5-Sep-2023
Update - Notification of buy-back - COH
1-Sep-2023
Notification regarding unquoted securities - COH
1-Sep-2023
Update - Notification of buy-back - COH
31-Aug-2023
Notification regarding unquoted securities - COH
30-Aug-2023
Notification regarding unquoted securities - COH
30-Aug-2023
Update - Notification of buy-back - COH
29-Aug-2023
Appendix 3Y - Diggory Howitt
29-Aug-2023
Notification regarding unquoted securities - COH
29-Aug-2023
Cochlear Capital Markets Day
28-Aug-2023
Notification regarding unquoted securities - COH
28-Aug-2023
Update - Notification of buy-back - COH
22-Aug-2023
Appendix 3Y - Michael del Prado
22-Aug-2023
Appendix 3Y - Michael Daniell
22-Aug-2023
Appendix 3Y - Diggory Howitt
22-Aug-2023
Notification of cessation of securities - COH
17-Aug-2023
Notification regarding unquoted securities - COH
15-Aug-2023
Appendix 4G
15-Aug-2023
2023 Corporate Governance Statement
15-Aug-2023
2023 Tax Contribution Report
15-Aug-2023
FY23 Result - Presentation
15-Aug-2023
FY23 Result - ASX & Media Release
15-Aug-2023
Dividend/Distribution - COH
15-Aug-2023
Annual Report (incl Sustainability reporting)
15-Aug-2023
Appendix 4E
14-Aug-2023
Application for quotation of securities - COH
31-Jul-2023
Application for quotation of securities - COH
28-Jul-2023
Late Lodgement of Appendix 3H
28-Jul-2023
Notification of cessation of securities - COH
18-Jul-2023
Retirement of Director - Andrew Denver
10-Jul-2023
COH Notice of FY23 result analyst and media briefing
7-Jul-2023
Notification of cessation of securities - COH
3-Jul-2023
Financial Calendar Key Dates FY24
3-Jul-2023
Update - Notification of buy-back - COH
30-Jun-2023
Update - Notification of buy-back - COH
29-Jun-2023
Update - Notification of buy-back - COH
28-Jun-2023
Update - Notification of buy-back - COH
23-Jun-2023
Update - Notification of cessation of securities - COH
23-Jun-2023
Update - Notification of cessation of securities - COH
22-Jun-2023
Oticon Medical Acquisition - UK CMA Final Report & Update
22-Jun-2023
Update - Notification of buy-back - COH
14-Jun-2023
Update - Notification of buy-back - COH
13-Jun-2023
Update - Notification of buy-back - COH
9-Jun-2023
Becoming a substantial holder
9-Jun-2023
Notification of cessation of securities - COH
9-Jun-2023
Update - Notification of buy-back - COH
7-Jun-2023
Update - Notification of buy-back - COH
6-Jun-2023
Update - Notification of buy-back - COH
5-Jun-2023
Update - Notification of buy-back - COH
1-Jun-2023
Update - Notification of buy-back - COH
30-May-2023
Update - Notification of buy-back - COH
26-May-2023
Update - Notification of buy-back - COH
25-May-2023
Update - Notification of buy-back - COH
24-May-2023
Update - Notification of buy-back - COH
22-May-2023
Update - Notification of buy-back - COH
19-May-2023
Notification of cessation of securities - COH
19-May-2023
Update - Notification of buy-back - COH
18-May-2023
Update - Notification of buy-back - COH
17-May-2023
Update - Notification of buy-back - COH
12-May-2023
Update - Notification of buy-back - COH
27-Apr-2023
Application for quotation of securities - COH
20-Apr-2023
Provisional findings from the UK CMA
20-Apr-2023
Update - Notification of buy-back - COH
19-Apr-2023
Update - Notification of buy-back - COH
18-Apr-2023
Notification regarding unquoted securities - COH
18-Apr-2023
Notification of cessation of securities - COH
18-Apr-2023
Update - Notification of buy-back - COH
17-Apr-2023
Update - Notification of buy-back - COH
14-Apr-2023
Update - Notification of buy-back - COH
6-Apr-2023
Update - Notification of buy-back - COH
4-Apr-2023
Update - Notification of buy-back - COH
3-Apr-2023
Update - Dividend/Distribution - COH
3-Apr-2023
Update - Notification of buy-back - COH
30-Mar-2023
Update - Notification of buy-back - COH
29-Mar-2023
Update - Notification of buy-back - COH
28-Mar-2023
Update - Notification of buy-back - COH
24-Mar-2023
Update - Notification of buy-back - COH
23-Mar-2023
Update - Notification of buy-back - COH
20-Mar-2023
Update - Notification of buy-back - COH
17-Mar-2023
Update - Notification of buy-back - COH
16-Mar-2023
Update - Notification of buy-back - COH
15-Mar-2023
Update - Notification of buy-back - COH
9-Mar-2023
Update - Notification of buy-back - COH
6-Mar-2023
Appendix 3Y - Michael del Prado
2-Mar-2023
Update - Notification of buy-back - COH
17-Feb-2023
Cochlear Limited - Revised Trading Policy
15-Feb-2023
Update - Dividend/Distribution - COH
15-Feb-2023
Notification of buy-back - COH
15-Feb-2023
HY23 Result - Presentation Slides
15-Feb-2023
HY23 Result - ASX & Media Release
15-Feb-2023
Dividend/Distribution - COH
15-Feb-2023
Appendix 4D and Half Year Financial Report
30-Jan-2023
Application for quotation of securities - COH
24-Jan-2023
Notice of HY23 result analyst and media briefing
12-Jan-2023
Notification of cessation of securities - COH
7-Dec-2022
Oticon Medical acquisition - UK CMA decision
1-Dec-2022
Acquisition of Oticon Medical-ACCC Statement
1-Dec-2022
AXX: Preliminary concerns Cochlear Oticon proposed acquisiti
3-Nov-2022
Notification regarding unquoted securities - COH
2-Nov-2022
Appendix 3Y - Michael del Prado
31-Oct-2022
Appendix 3Y - Alison Deans
28-Oct-2022
Appendix 3Y - Bruce Robinson
26-Oct-2022
Application for quotation of securities - COH
24-Oct-2022
Appendix 3Y - Karen Penrose
24-Oct-2022
Application for quotation of securities - COH
20-Oct-2022
Appendix 3Y - Diggory Howitt
20-Oct-2022
Notification regarding unquoted securities - COH
18-Oct-2022
2022 AGM Results
18-Oct-2022
2022 AGM Chair and CEO & President Addresses
12-Oct-2022
Notification of cessation of securities - COH
6-Oct-2022
Appendix 3Y - Diggory Howitt
6-Oct-2022
Notification regarding unquoted securities - COH
4-Oct-2022
Update - Dividend/Distribution - COH
23-Sep-2022
Notification regarding unquoted securities - COH
16-Sep-2022
COH Notice of Annual General Meeting and Voting Form
16-Sep-2022
Update - Dividend/Distribution - COH
9-Sep-2022
Appendix 3Y - Karen Penrose
2-Sep-2022
Appendix 3Y - Michael del Prado
31-Aug-2022
Appendix 3Y - Michael del Prado
26-Aug-2022
Appendix 3Y - Karen Penrose
26-Aug-2022
Appendix 3Y - Christine Frances McLoughlin
25-Aug-2022
Appendix 3Y - Michael Daniell
24-Aug-2022
Notification of cessation of securities - COH
19-Aug-2022
Application for quotation of securities - COH
19-Aug-2022
Appendix 4G
19-Aug-2022
2022 Corporate Governance Statement
19-Aug-2022
2022 Tax Contribution Report
19-Aug-2022
2022 Sustainability Report
19-Aug-2022
FY22 Result Presentation
19-Aug-2022
FY22 Result - ASX & Media Release
19-Aug-2022
Dividend/Distribution - COH
19-Aug-2022
2022 Annual Report
19-Aug-2022
Appendix 4E
9-Aug-2022
Date of AGM and closing date for director nominations
29-Jul-2022
Application for quotation of securities - COH
25-Jul-2022
COH Notice of FY22 result analyst and media briefing
13-Jul-2022
Notification of cessation of securities - COH
1-Jul-2022
Appendix 3X - Karen Penrose
17-Jun-2022
Ceasing to be a substantial holder
27-May-2022
Appointment to Cochlear Board - Karen Penrose
5-May-2022
Application for quotation of securities - COH
27-Apr-2022
Cochlear agrees to acquire Oticon Medical
12-Apr-2022
Notification of cessation of securities - COH
7-Apr-2022
Change in substantial holding
29-Mar-2022
Notification of cessation of securities - COH
22-Feb-2022
Half Year Results Presentation
22-Feb-2022
Half Year Results Announcement
22-Feb-2022
Dividend/Distribution - COH
22-Feb-2022
Appendix 4D and Half Year Financial Report
1-Feb-2022
Application for quotation of securities - COH
13-Jan-2022
Notification of cessation of securities - COH
11-Jan-2022
Notice of HY22 result analyst and media briefing
5-Jan-2022
Appendix 3X - Michael del Prado
17-Dec-2021
Appointment of Michael del Prado to Cochlear Board
8-Dec-2021
Change in leadership for Cochlear North America
15-Nov-2021
Becoming a substantial holder
11-Nov-2021
Jobkeeper Payments Notification
3-Nov-2021
Ceasing to be a substantial holder
29-Oct-2021
Appendix 3Y - Christine Frances McLoughlin
29-Oct-2021
Notification regarding unquoted securities - COH
26-Oct-2021
Notification regarding unquoted securities - COH
22-Oct-2021
Appendix 3Y - Diggory Howitt
22-Oct-2021
Becoming a substantial holder
21-Oct-2021
Notification regarding unquoted securities - COH
19-Oct-2021
Results of Meeting
19-Oct-2021
2021 Cochlear AGM Presentation to Shareholders
14-Oct-2021
Notification of cessation of securities - COH
8-Oct-2021
Application for quotation of securities - COH
6-Oct-2021
Appendix 3Y - Diggory Howitt
6-Oct-2021
Notification regarding unquoted securities - COH
24-Sep-2021
Cochlear advises of US patent infringement complaint
23-Sep-2021
Notification regarding unquoted securities - COH
16-Sep-2021
COH Notice of Annual General Meeting and Proxy/Voting Form
14-Sep-2021
Notification regarding unquoted securities - COH
9-Sep-2021
Appendix 3Y - Diggory Howitt
7-Sep-2021
Notification regarding unquoted securities - COH
2-Sep-2021
Notification regarding unquoted securities - COH
27-Aug-2021
Notification of cessation of securities - COH
27-Aug-2021
Appendix 3Y - Christine Frances McLoughlin
26-Aug-2021
Notification regarding unquoted securities - COH
25-Aug-2021
Appendix 3Y - Diggory Howitt
24-Aug-2021
Notification regarding unquoted securities - COH
23-Aug-2021
Appendix 3Z - Rick Holliday-Smith
20-Aug-2021
Application for quotation of securities - COH
20-Aug-2021
Appendix 4G
20-Aug-2021
2021 Corporate Governance Statement
20-Aug-2021
2021 Tax Contribution Report
20-Aug-2021
2021 Sustainability Report
20-Aug-2021
FY21 Result Presentation
20-Aug-2021
FY21 Result - ASX & Media Release
20-Aug-2021
Dividend/Distribution - COH
20-Aug-2021
2021 Annual Report
20-Aug-2021
Appendix 4E
10-Aug-2021
Date of AGM and closing date for director nominations
23-Jul-2021
Appendix 3Z - Abbas Hussain
22-Jul-2021
COH Notice of FY21 result analyst and media briefing
20-Jul-2021
Resignation of Director - Abbas Hussain
13-Jul-2021
Notification of cessation of securities - COH
30-Jun-2021
Becoming a substantial holder
30-Jun-2021
Ceasing to be a substantial holder
24-Jun-2021
Becoming a substantial holder
7-Jun-2021
Change in substantial holding
31-May-2021
Becoming a substantial holder
31-May-2021
Cochlear announces new Chair
20-May-2021
Change in substantial holding
17-May-2021
Becoming a substantial holder
3-May-2021
Change in substantial holding
27-Apr-2021
Change in substantial holding
11-Mar-2021
Appendix 2A
1-Mar-2021
Appendix 3Y - Alison Deans
24-Feb-2021
COH receives FDA approval for Baha 6 Max Sound Processor
19-Feb-2021
HY21 Result Presentation Slides
19-Feb-2021
COH HY21 Result ASX & Media Release
19-Feb-2021
Dividend/Distribution - COH
19-Feb-2021
Half Yearly Report and Accounts
12-Feb-2021
Appointment of Stu Sayers as CFO
9-Feb-2021
Appendix 2A
21-Jan-2021
Notice of HY21 result analyst and media briefing
15-Dec-2020
Stu Sayers appointed Acting CFO
15-Dec-2020
Denial of Appeal in US patent infringement case
13-Nov-2020
Typographical Errors in the Constitution of Cochlear
11-Nov-2020
Appendix 2A
2-Nov-2020
Appendix 3X - Christine Frances McLoughlin
29-Oct-2020
Appendix 2A
23-Oct-2020
Appendix 3G
22-Oct-2020
Appendix 3Z - Donal O'Dwyer
22-Oct-2020
Appendix 3G
22-Oct-2020
Appendix 3Y - Diggory Howitt
21-Oct-2020
Appendix 2A
20-Oct-2020
New Constitution of Cochlear Limited
20-Oct-2020
Results of Meeting
20-Oct-2020
2020 Cochlear AGM Presentation to Shareholders
20-Oct-2020
First quarter trading update
25-Sep-2020
Appendix 3G
21-Sep-2020
Appendix 2A
18-Sep-2020
COH Notice of Annual General Meeting and Proxy/Voting Form
9-Sep-2020
Appendix 3Y - Bruce Robinson
1-Sep-2020
Appendix 3Y - Bruce Robinson
28-Aug-2020
Publication of global consensus paper
28-Aug-2020
Appendix 3Y - Abbas Hussain
27-Aug-2020
Change in substantial holding
26-Aug-2020
Appendix 2A
26-Aug-2020
Appendix 3Y - Diggory Howitt
24-Aug-2020
Appendix 2A
24-Aug-2020
Appendix 2A
24-Aug-2020
Appendix 2A
21-Aug-2020
Appendix 2A
20-Aug-2020
Corrections to 2020 Annual Report
20-Aug-2020
Appendix 2A
20-Aug-2020
Appendix 3Y - Diggory Howitt
18-Aug-2020
Appendix 2A
18-Aug-2020
AGM date & Director nominations
18-Aug-2020
2020 Tax Contribution Report
18-Aug-2020
Appendix 4G
18-Aug-2020
2020 ESG Report
18-Aug-2020
2020 Corporate Governance Statement
18-Aug-2020
2020 Annual Report
18-Aug-2020
2020 Strategy Overview
18-Aug-2020
FY20 Result Presentation Slides
18-Aug-2020
FY20 result - ASX & media release
18-Aug-2020
Appendix 4E
17-Aug-2020
Appointment to Cochlear Board - Christine McLoughlin
17-Aug-2020
Intention to Retire from Cochlear Board - Donal O'Dwyer
17-Aug-2020
Settlement in US Patent Infringement Case
7-Aug-2020
COH Notice of FY20 result analyst and media briefing
27-Jul-2020
Cochlear Limited - Revised Trading Policy
13-Jul-2020
Resignation of CFO
3-Jul-2020
Cochlear advises of FDA approval for four new products
29-Jun-2020
Appendix 3Y - Bruce Robinson
19-May-2020
Denial of appeal rehearing in US patent infringement case
11-May-2020
Confirmation of COVID-19 pandemic impact on trading
6-May-2020
Appendix 3Y - Donal O'Dwyer
6-May-2020
Appendix 3Y - Andrew Denver
5-May-2020
Appendix 3Y - Bruce Robinson
5-May-2020
Appendix 3Y - Yasmin Allen
4-May-2020
Appendix 3Y - Abbas Hussain
4-May-2020
Appendix 3Y - Rick Holliday-Smith
4-May-2020
Appendix 3Y - Michael Daniell
4-May-2020
Appendix 3Y - Glen Boreham
4-May-2020
Appendix 3Y - Diggory Howitt
4-May-2020
Appendix 3Y - Alison Deans
1-May-2020
Change in substantial holding
30-Apr-2020
Appendix 2A
28-Apr-2020
Cochlear Completes Share Purchase Plan
8-Apr-2020
Cochlear receives expedited FDA approval of Remote Check
7-Apr-2020
Temporary pay reduction for Board, CEO & senior executives
2-Apr-2020
Becoming a substantial holder
1-Apr-2020
Cochlear Share Purchase Plan Offer Open
30-Mar-2020
Appendix 2A
27-Mar-2020
Appendix 3B - Update to Proposed Issue of Securities - COH
17-Mar-2020
Adverse appeal decision in the US patent infringement case
16-Mar-2020
Cochlear withdraws FY20 earnings guidance due to coronavirus
12-Mar-2020
Appendix 2A
18-Feb-2020
HY20 Result Presentation Slides
18-Feb-2020
HY20 Result ASX & Media Release
18-Feb-2020
Dividend/Distribution - COH
18-Feb-2020
Half Yearly Report and Accounts
13-Feb-2020
Cochlear announces additional investment in Nyxoah
11-Feb-2020
Cochlear reduces earnings guidance due to coronavirus
6-Jan-2020
Initial Director's Interest Notice - Appendix 3X M G Daniell
11-Dec-2019
Change in substantial holding
10-Dec-2019
Appointment of Michael Daniell to the Cochlear Limited Board
21-Nov-2019
Appendix 3B
18-Nov-2019
FDA Clearance for Cochlear Osia 2 System
8-Nov-2019
Appendix 3B
4-Nov-2019
Appendix 3B
1-Nov-2019
Appendix 3B
28-Oct-2019
Appendix 3Y - Diggory Howitt
25-Oct-2019
Appendix 3B
25-Oct-2019
Appendix 3B
24-Oct-2019
Appendix 3B
22-Oct-2019
Correction - 2019 AGM Presentations to Shareholders
22-Oct-2019
COH 2019 AGM - Results of Meeting
22-Oct-2019
2019 Cochlear AGM Presentation to Shareholders
22-Oct-2019
2019 Chairman's AGM Address to Shareholders
22-Oct-2019
Change in substantial holding
15-Oct-2019
Appendix 3B
30-Sep-2019
Appendix 3B
30-Sep-2019
Appendix 3B
20-Sep-2019
Appendix 3Y - Diggory Howitt
17-Sep-2019
Appendix 3B
17-Sep-2019
COH Notice of Annual General Meeting
17-Sep-2019
COH Chairmans Letter and Proxy/Voting Form
16-Sep-2019
Ceasing to be a substantial holder
6-Sep-2019
Appendix 3B
4-Sep-2019
Ceasing to be a substantial holder
3-Sep-2019
Appendix 3B
30-Aug-2019
Appendix 3Y - Diggory Howitt
30-Aug-2019
Appendix 3B
28-Aug-2019
Appendix 3B
27-Aug-2019
Appendix 3Y - Abbas Hussain
23-Aug-2019
Appendix 3B
23-Aug-2019
Appendix 3Y - Diggory Howitt
22-Aug-2019
Appendix 3B
21-Aug-2019
Appendix 3B
16-Aug-2019
Appendix 3B
16-Aug-2019
Appendix 4G
16-Aug-2019
2019 Tax Contribution Report
16-Aug-2019
2019 ESG Report
16-Aug-2019
2019 Corporate Governance Statement
16-Aug-2019
2019 Annual Report
16-Aug-2019
2019 Strategy Overview
16-Aug-2019
FY19 Result Presentation Slides
16-Aug-2019
FY19 Results ASX & Media Release
16-Aug-2019
Dividend/Distribution - COH
16-Aug-2019
Appendix 4E
29-Jul-2019
Becoming a substantial holder
16-Jul-2019
Ceasing to be a substantial holder - amended
15-Jul-2019
Ceasing to be a substantial holder
17-Jun-2019
COH - Profile Plus FDA Approval
10-May-2019
COH Hosts Capital Markets Day 10 May 2019
16-Apr-2019
Cochlear announces launch of Nucleus Profile Plus implant
8-Mar-2019
UK cochlear implant criteria change
5-Mar-2019
Becoming a substantial holder from PNI
4-Mar-2019
Becoming a substantial holder
4-Mar-2019
Change of Director's Interest Notice
19-Feb-2019
COH Half Year Results Analyst - 19.02.2019
19-Feb-2019
COH Half Year Results Media Release - 19.02.2019
19-Feb-2019
Dividend/Distribution - COH
19-Feb-2019
Half Yearly Report and Accounts
11-Jan-2019
Appendix 3B
27-Nov-2018
Becoming a substantial holder
22-Nov-2018
Initial Director's Interest Notice - Appendix 3X S A Hussain
22-Nov-2018
Ceasing to be a substantial holder
21-Nov-2018
Becoming a substantial holder
20-Nov-2018
Appointment of Abbas Hussain to Cochlear Limited Board
14-Nov-2018
Appendix 3Y - Diggory Howitt
13-Nov-2018
COH Invest in Nyxoah
12-Nov-2018
Appendix 3B
12-Nov-2018
Appendix 3Y - Diggory Howitt
8-Nov-2018
Cochlear & GN Hearing Strengthen Tech & Commercial Alliance
6-Nov-2018
Appendix 3B
5-Nov-2018
COH - Ruling in USA Patent Infringement Case
31-Oct-2018
Appendix 3Y - Diggory Howitt
31-Oct-2018
Appendix 3Y - Bruce Robinson
24-Oct-2018
Appendix 3B
23-Oct-2018
Appendix 3Y - Bruce Robinson
19-Oct-2018
Appendix 3Z - Prof Edward Byrne
19-Oct-2018
Appendix 3B
16-Oct-2018
COH 2018 AGM - Results of Meeting
16-Oct-2018
2018 Cochlear AGM Presentation to Shareholders
16-Oct-2018
2018 Chairman's AGM Address to Shareholders
11-Oct-2018
Appendix 3B
11-Oct-2018
Appendix 3B
10-Oct-2018
Next phase development - totally implantable cochlear device
24-Sep-2018
Appendix 3B
12-Sep-2018
COH Chairman's Letter and Proxy/Voting Form
12-Sep-2018
COH Notice of Annual General Meeting
3-Sep-2018
Appendix 3B
3-Sep-2018
Appendix 3B
30-Aug-2018
Appendix 3Y - Diggory Howitt
28-Aug-2018
Appendix 3B
28-Aug-2018
Appendix 3Y - Diggory Howitt
24-Aug-2018
Appendix 3B
22-Aug-2018
Appendix 3Y - Diggory Howitt
21-Aug-2018
Appendix 3B
20-Aug-2018
Appendix 3Y - Bruce Robinson
15-Aug-2018
Appendix 3B
14-Aug-2018
Appendix 3B
14-Aug-2018
Appendix 4G
14-Aug-2018
COH 2018 Tax Contribution Report
14-Aug-2018
COH 2018 Corporate Governance Statement
14-Aug-2018
COH Investor Handbook - Aug 18
14-Aug-2018
COH 2018 Annual Report to shareholders
14-Aug-2018
COH FY18 Result Presentation Slides
14-Aug-2018
COH FY18 Result Announcement
14-Aug-2018
Dividend/Distribution - COH
14-Aug-2018
Full Year Statutory Accounts - COH Appendix 4E
13-Aug-2018
Director Appointment/Resignation
22-Jun-2018
COH announces release of Nucleus Smart App for Android
8-Jun-2018
S&P DJI Announces June Quarterly Rebalance
4-May-2018
COH Hosts Investor Day 4 May 2018
3-Apr-2018
Ceasing to be a substantial holder
28-Mar-2018
Becoming a substantial holder
26-Mar-2018
Amended Notice - Becoming a substantial holder
13-Mar-2018
Becoming a substantial holder
7-Mar-2018
Appendix 3Y - Dig Howitt
22-Feb-2018
Appendix 3B
13-Feb-2018
Ceasing to be a substantial holder
13-Feb-2018
Ceasing to be a substantial holder
13-Feb-2018
COH Half Year Results Analyst Presentation
13-Feb-2018
COH Half Year Results Media Release 13.02.2018
13-Feb-2018
Dividend/Distribution - COH
13-Feb-2018
Half Year Accounts
5-Feb-2018
Response to ASX query on Appendix 3Y
8-Jan-2018
Appendix 3Z - Chris Smith
22-Dec-2017
Change in substantial holding
13-Dec-2017
Appendix 3Y - Chris Smith
16-Nov-2017
Initial Director's Interest Notice
14-Nov-2017
COH CEO Transition and Related Board Changes
20-Oct-2017
Appendix 3B
20-Oct-2017
Appendix 3B
17-Oct-2017
COH 2017 AGM - Results of Meeting
17-Oct-2017
2017 Chairman's AGM Address to Shareholders
17-Oct-2017
2017 Cochlear AGM Presentation to Shareholders
9-Oct-2017
Appendix 3B
27-Sep-2017
Appendix 3B
25-Sep-2017
Appendix 3B
14-Sep-2017
Appendix 3Y - Alison Deans
14-Sep-2017
Appendix 3B
13-Sep-2017
AGM Proxy Form
13-Sep-2017
Notice of Annual General Meeting
11-Sep-2017
Appendix 3Y - Bruce Robinson
1-Sep-2017
Appendix 3B
30-Aug-2017
Appendix 3Y - Chris Smith
30-Aug-2017
Appendix 3B
29-Aug-2017
Appendix 3B
29-Aug-2017
Appendix 3B
28-Aug-2017
Appendix 3B
25-Aug-2017
Corrected - Appendix 3Y - Chris Smith
25-Aug-2017
Appendix 3Y - Chris Smith
22-Aug-2017
Appendix 3B
18-Aug-2017
Appendix 3Y - Chris Smith
18-Aug-2017
Appendix 3B
18-Aug-2017
Appendix 3B
17-Aug-2017
Appendix 3B
17-Aug-2017
Appendix 4G
17-Aug-2017
COH 2017 Tax Contribution Report
17-Aug-2017
COH 2017 Corporate Governance Statement
17-Aug-2017
COH Investor Handbook Aug17
17-Aug-2017
COH 2017 Annual Report
17-Aug-2017
COH FY17 Result Presentation Slides
17-Aug-2017
COH FY17 Result Announcement
17-Aug-2017
Dividend/Distribution - COH
17-Aug-2017
Appendix 4E
31-Jul-2017
Director Appointment/Resignation
26-Jul-2017
Change in substantial holding
13-Jul-2017
COCHLEAR TO EXPAND GLOBAL CAPACITY
5-Jul-2017
Ceasing to be a substantial holder
22-Jun-2017
Becoming a substantial holder
12-May-2017
Change in substantial holding
11-May-2017
Cochlear acquires audiology practice management software
4-May-2017
Cochlear Investor Day Presentations - Corrections
4-May-2017
COH Hosts Investor Day 4 May 2017
1-May-2017
Change in substantial holding
6-Apr-2017
COH Half Year Report F17
20-Feb-2017
Ceasing to be a substantial holder
14-Feb-2017
COH Half Year Results Analyst Presentation
14-Feb-2017
COH Half Year Results Media Release
14-Feb-2017
Dividend/Distribution - COH
14-Feb-2017
Half Yearly Report and Accounts
13-Feb-2017
COH RESIGNATION & APPOINTMENT OF COMPANY SECRETARY
10-Feb-2017
COH Announcement of New CFO
25-Jan-2017
Becoming a substantial holder
23-Dec-2016
Appendix 3B
16-Dec-2016
Appendix 3X
13-Dec-2016
Appointment of Prof Bruce Robinson as non-executive Director
28-Nov-2016
Change in substantial holding
18-Nov-2016
Decision in US Patent Infringement Case
11-Nov-2016
Appendix 3B
9-Nov-2016
Change of Director's Interest Notice - Chris Smith
7-Nov-2016
Appendix 3B
3-Nov-2016
Appendix 3B
1-Nov-2016
Appendix 3B
21-Oct-2016
Appendix 3B
21-Oct-2016
Appendix 3B
18-Oct-2016
COH 2016 AGM - Results of Meeting
18-Oct-2016
2016 Cochlear AGM Presentation to Shareholders
18-Oct-2016
2016 Chairman's AGM Address to Shareholders
14-Oct-2016
Becoming a substantial holder
5-Oct-2016
Appendix 3B
29-Sep-2016
Retirement of Chief Financial Officer
14-Sep-2016
Voting Form
14-Sep-2016
Notice of Annual General Meeting
13-Sep-2016
Appendix 3Y - Chris Smith
13-Sep-2016
Appendix 3B
2-Sep-2016
Appendix 3B
31-Aug-2016
Appendix 3B
26-Aug-2016
Appendix 3B
19-Aug-2016
Appendix 3B
18-Aug-2016
Appendix 3Y - Chris Smith
15-Aug-2016
Appendix 3B
12-Aug-2016
Appendix 3B
9-Aug-2016
COH Investor Handbook
9-Aug-2016
Dividend/Distribution - COH
9-Aug-2016
COH 2016 Tax Contribution Report
9-Aug-2016
Appendix 4G
9-Aug-2016
COH 2016 Corporate Governance Statement
9-Aug-2016
COH 2016 Annual Report
9-Aug-2016
COH FY16 Result Presentation Slides
9-Aug-2016
COH FY16 Result Announcement
9-Aug-2016
Appendix 4E
28-Jul-2016
COH Senior Executive Appointments
13-May-2016
Becoming a substantial holder
28-Apr-2016
Cochlear Hosts Investor Day 28 April 2016
14-Apr-2016
Appendix 3B
1-Apr-2016
Appendix 3Y - Rick Holliday-Smith
31-Mar-2016
Half Year Report 2016
7-Mar-2016
Appendix 3B
1-Mar-2016
Appendix 3B
16-Feb-2016
Ceasing to be a substantial holder
16-Feb-2016
Change in substantial holding
11-Feb-2016
COH Half Year Results Analyst Presentation
11-Feb-2016
COH Half Year Results Media Release 11.02.2016
11-Feb-2016
Dividend/Distribution - COH
11-Feb-2016
Half Year Report & Accounts
20-Nov-2015
Appendix 3B
5-Nov-2015
Appendix 3Y - Chris Smith
28-Oct-2015
Appendix 3Y - Chris Smith
20-Oct-2015
COH 2015 AGM - Results of Meeting
20-Oct-2015
20/10/15 Cochlear AGM Presentation to Shareholders
20-Oct-2015
20/10/15 Chairman's AGM Address to Shareholders
9-Oct-2015
Appendix 3B - Cochlear Employee Share Plan
18-Sep-2015
Form - Questions from Shareholders
18-Sep-2015
Voting Form
18-Sep-2015
Invitation letter from Chairman - AGM
18-Sep-2015
Notice of Annual General Meeting
15-Sep-2015
Appendix 3Y - Chris Smith
8-Sep-2015
Appendix 3B
5-Sep-2015
Change in substantial holding
4-Sep-2015
Appendix 3X - Chris Smith
1-Sep-2015
Appendix 3Z - Chris Roberts
1-Sep-2015
Appendix 3B
31-Aug-2015
Appendix 3B
31-Aug-2015
CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES
27-Aug-2015
Appendix 3Y - Chris Roberts
25-Aug-2015
Appendix 3B
24-Aug-2015
Appendix 3Y - Glen Boreham
21-Aug-2015
Appendix 3Y - Dr Chris Roberts
17-Aug-2015
Appendix 3Y - Rick Holliday-Smith
12-Aug-2015
Dividend/Distribution - COH
11-Aug-2015
Full Year Results Analyst Presentation
11-Aug-2015
Full Year Statutory Accounts and Annual Report
30-Jun-2015
Updated Trading Policy
26-May-2015
COH Chris Smith Announced as Incoming CEO of Cochlear
21-Apr-2015
Judgment in United States Patent Infringement Laws
1-Apr-2015
DECISION IN US PATENT INFRINGEMENT CASE
26-Mar-2015
Half Year Report 2015
13-Mar-2015
Ceasing to be a substantial holder
10-Mar-2015
Appendix 3Y - Alison Deans
6-Mar-2015
Appendix 3Y - Chris Roberts
10-Feb-2015
COH Half Year Results Analyst Presentation
10-Feb-2015
COH Half Year Results Media Release 10.02.2015
10-Feb-2015
Half Year Report & Accounts
9-Dec-2014
Director Appointment
9-Dec-2014
Director Appointment
14-Oct-2014
COH 2014 AGM - Results of Meeting
14-Oct-2014
Cochlear AGM Presentation to Shareholders
14-Oct-2014
Chairman's AGM Address to Shareholders
5-Aug-2014
COH Full Year Results Analyst Presentation 05.08.2014
5-Aug-2014
COH Full Year Results Media Release 05.08.14
5-Aug-2014
Preliminary Final Report and Full Year Statutory Accounts
2-Jun-2014
COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP
27-Mar-2014
Half Year Report 2014
21-Mar-2014
FDA approves Cochlear Nucleus Hybrid for sale in USA
11-Feb-2014
COH Half Year Results Analyst Presentaton
11-Feb-2014
COH Half Year Results Media Release
11-Feb-2014
Half Year Report & Accounts
24-Jan-2014
COH Jury Trial Verdict on USA Patent Infringement Case
11-Nov-2013
FDA Advisory panel votes favourably on Hybrid hearing device
15-Oct-2013
Cochlear 2013 AGM - Results of Meeting
15-Oct-2013
Cochlear AGM Presentation to Shareholders
15-Oct-2013
Chairman's AGM Address to Shareholders
6-Aug-2013
Full Year Results Analyst Presentation
6-Aug-2013
Cochlear F'13 Full Year Results
6-Aug-2013
Full Year Financial Statements 4E 30 June 2013
17-Jun-2013
UBS Australian Healthcare Conference 2013 Presentation
3-Jun-2013
Cochlear update on Nucleus 6 launch and trading conditions
12-Mar-2013
F'13 Half Year Report
5-Feb-2013
Half Year Results Analyst Presentation
5-Feb-2013
Cochlear F'13 Half Year Results
5-Feb-2013
Financial Statements
16-Oct-2012
Cochlear 2012 AGM - Results of Meeting
16-Oct-2012
Cochlear AGM Presentation to Shareholders
16-Oct-2012
Chairman's AGM Address to Shareholders
7-Aug-2012
Full Year Results Analyst Presentation
7-Aug-2012
Update on Nucleus CI500 series implant recall
7-Aug-2012
F'12 Full Year Results
7-Aug-2012
Financial Statements
30-Apr-2012
Cochlear to vigorously patent infringement complaint
13-Mar-2012
F'12 Half Yearly Report
7-Feb-2012
Half Year Results Analyst Presentation
7-Feb-2012
F'12 Half Yearly Results
7-Feb-2012
Financial Statements
20-Dec-2011
Update on Nucleus CI500 Series Implant Recall
18-Oct-2011
Cochlear 2011 AGM - Results of Voting
18-Oct-2011
Cochlear AGM Presentation to Shareholders
18-Oct-2011
Chairman`s AGM Address to Shareholders
26-Sep-2011
Letter to Shareholders
12-Sep-2011
Cochlear announces voluntary recall of Nucleus CI500 cochlear implant range
9-Aug-2011
Full Year Results Analyst Presentation
9-Aug-2011
F'11 Full Year Results
9-Aug-2011
Financial Statements
8-Feb-2011
Half Year Results Analyst Presentation
8-Feb-2011
F' 11 Half Yearly Results
8-Feb-2011
Half Year Report and Accounts
19-Oct-2010
Cochlear 2010 AGM - Results of Meeting
19-Oct-2010
Chairman`s AGM Address to Shareholders
19-Oct-2010
Cochlear AGM Presentation to Shareholders
10-Aug-2010
Full Year Results Analyst Presentation
10-Aug-2010
F'10 Full Year Results
10-Aug-2010
Financial Statements
2-Aug-2010
Cochlear announces appointment of Non-Executive Director
4-Jun-2010
Settlement Agreement with the DOJ and OIG
17-Mar-2010
Cochlear Ltd Announces Appointment of New Chairman
15-Mar-2010
F'10 Half Yearly Report
9-Feb-2010
Half Year Results Analyst Presentation
9-Feb-2010
F'10 Half Year Results
9-Feb-2010
Financial Statements
20-Oct-2009
Cochlear 2009 AGM Results of Voting
20-Oct-2009
Cochlear AGM Presentation to Shareholders
20-Oct-2009
Chairmans AGM Address to Shareholders
4-Sep-2009
FDA Approval for Nucleus 5 System
11-Aug-2009
Full Year Results Analyst Presentation
11-Aug-2009
F'09 Full Year Results
11-Aug-2009
Financial Statements
14-Jul-2009
Cochlear Market Update
4-Jun-2009
Cochlear completes debt refinancing
3-Jun-2009
Conclusion of agreements for new global headquarters
16-Mar-2009
F'09 Half Year Report
10-Feb-2009
Half Year Results Analyst Presentation
10-Feb-2009
F'09 Half Year Results
10-Feb-2009
Financial Statements
21-Oct-2008
Cochlear 2008 AGM Results of Meeting
21-Oct-2008
Chairmans AGM Address to Shareholders
21-Oct-2008
Cochlear AGM Presentation to Shareholders
16-Sep-2008
Proxy Form
16-Sep-2008
Chairman`s Letter to Shareholders
16-Sep-2008
Notice of Annual General Meeting
16-Sep-2008
Annual Report to shareholders - Financial
16-Sep-2008
Annual Report to shareholders - Editorial
12-Aug-2008
Full Year Results Analyst Presentation
12-Aug-2008
F'08 Full Year Results
12-Aug-2008
Financial Statements
17-Mar-2008
F'08 Half Yearly Report
22-Feb-2008
COH to Work with FDA to Resolve Issues in Warning Letter
12-Feb-2008
Half Year Analyst Presentation
12-Feb-2008
F'08 Half Yearly Report
12-Feb-2008
Financial Statements
21-Dec-2007
Cochlear to Vigorously Defend Patent Infringement Complaint
23-Oct-2007
Cochlear 2006 AGM Results of Meeting
23-Oct-2007
Cochlear's plans for new Sydney Global Headquarters
23-Oct-2007
Chairman's AGM Address to Shareholders
23-Oct-2007
Cochlear AGM Presentation to Shareholders
14-Aug-2007
Full Year Results Analyst Presentation
14-Aug-2007
Financial Statements
14-Aug-2007
F'07 Full Year Results
13-Feb-2007
F'07 Half Year Results Analyst Presentation
13-Feb-2007
F'07 Half Year Results
13-Feb-2007
Half Yearly Report & Half Year Accounts
19-Dec-2006
Cochlear acquires key supplier's operations
15-Dec-2006
Appointment of Director: Mr Andrew Denver
30-Oct-2006
Annual Report
25-Oct-2006
Cochlear 2006 AGM Results of Meeting
24-Oct-2006
AGM Presentation to Shareholders
24-Oct-2006
Chairman's Address to Shareholders
15-Aug-2006
Full Year Results Analyst Presentation
15-Aug-2006
F'06 Full Year Results
15-Aug-2006
Financial Statements
18-Jul-2006
Cochlear Board Changes
8-Jun-2006
Cochlear Limited Wins Gold in New York
5-May-2006
Cochlear announces approximately $270m order for China
10-Mar-2006
Cochlear Limited Response to Share Price Increase
14-Feb-2006
Half Yearly Results Analyst Presentation
14-Feb-2006
F'06 Half Year Results
14-Feb-2006
Financial statements